GCTK has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
GCTK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:
1. GuruFocus internally developed valuations of the stock, such as GF valuation.Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.
Based on those aspects listed above, GuruFocus believes the risk assessment of GlucoTrack is: No Data: Cannot be evaluated.
For the Medical Instruments & Supplies subindustry, GlucoTrack's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, GlucoTrack's Risk Assessment distribution charts can be found below:
* The bar in red indicates where GlucoTrack's Risk Assessment falls into.
GlucoTrack (NAS:GCTK) Risk Assessment Explanation
Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:
(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.
Thank you for viewing the detailed overview of GlucoTrack's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.
James S Cardwell | officer: Chief Financial Officer | CLINTON SQUARE, 75 S. CLINTON AVE., SUITE 510, ROCHESTER NY 14604 |
Erin Catherine Carter | director | 301 RTE 17 NORTH, STE. 800, RUTHERFORD NJ 07070 |
Allen Danzig | director | 301 RT 17 NORTH, SUITE 800, RUTHERFORD NJ 07070 |
Shimon D Rapps | director | C/O ANDREW GARRETT, INC., 52 VANDERBILT AVENUE SUITE 510, NEW YORK NY 10017 |
Drew Sycoff | director | C/O ANDREW GARRETT INC, 52 VANDERBILT AVENUE - 20TH FLOOR, NEW YORK NY 10017 |
David Podwalski | officer: Chief Commercial Officer | 19 HA'YAHALOMIM ST., P.O. BOX 12163, ASHDOD L3 7760049 |
Michael Hauck | director | 19 HA'YAHALOMIM ST., P.O. BOX 12163, C/O INTEGRITY APPLICATIONS, INC., ASHDOD L3 7760049 |
John A Graham | director, officer: Chief Executive Officer | 19 HA'YAHALOMIM STREET, P.O. BOX 12163, ASHDOD L3 7760049 |
Sami Sassoun | officer: Chief Financial Officer | 39-06 ACKERMAN DRIVE, FAIR LAWN L3 7760049 |
Philip Darivoff | director | 1 FARMSTEAD ROAD, SHORT HILLS NJ 07078 |
Revan Schwartz | director | 19 HA'YAHALOMIM ST., P.O. BOX 12163, C/O INTEGRITY APPLICATIONS, INC., ASHDOD L3 7760049 |
Angela Strand Boydston | director | C/O AEROGEN, INC., 2071 STIERLIN COURT, MOUNTAIN VIEW CA 94043 |
Leslie Seff | director | PO BOX 59, 40 HELLBROOK LANE, ULSTER PARK NY 12487 |
Eran Hertz | officer: Chief Financial Officer | C/O INTEGRITY APPLICATIONS, INC., 102 HA'AVODA STREET, P.O. BOX 432, ASHKELON L3 L3 78100 |
Israel B. Ehrlich | director | C/O INTEGRITY APPLICATIONS, INC., 102 HA'AVODA STREET, P.O. BOX 432, ASHKELON L3 L378100 |
From GuruFocus
By Value_Insider Value_Insider • 10-14-2022
By Marketwired Marketwired • 04-21-2021
By Marketwired Marketwired • 11-05-2020
By Marketwired • 08-28-2023
By sperokesalga sperokesalga • 04-12-2023
By GlobeNewswire GlobeNewswire • 12-20-2021
By GuruFocusNews GuruFocusNews • 11-29-2021
By GlobeNewswire GlobeNewswire • 04-12-2023
By ACCESSWIRE • 07-26-2023
By Marketwired • 10-12-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.